Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cartesian Therapeutics, Inc (RNAC)  
$10.39 0.29 (2.72%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 17,796,000
Market Cap: 184.90(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $8.77 - $27.01
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 13.4
Insider 6 Months    : 16.4
Insider 3/6 Months : 30.2
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Selecta Biosciences is a clinical-stage biopharmaceutical company. Co.'s ImmTOR® platform encapsulates rapamycin, also known as sirolimus, a Food and Drug Administration approved immunomodulator, in biodegradable nanoparticles ImmTOR is designed to induce antigen-specific immune tolerance. By combining ImmTOR with antigens of interest, Co.'s immune tolerance platform restores self-tolerance to auto-antigens in autoimmune diseases, amplify the ability of biologics (including gene therapies) and mitigate the formation of anti-drug antibodies against biologic drugs.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 149,075 259,905 533,331 1,756,647
Total Buy Value $1,522,517 $3,260,025 $8,715,809 $9,404,872
Total People Bought 1 1 2 2
Total Buy Transactions 6 11 19 32
Total Shares Sold 0 36,362 88,715 92,352
Total Sell Value $0 $610,064 $1,604,228 $1,608,083
Total People Sold 0 6 6 7
Total Sell Transactions 0 12 17 19
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 332
  Page 1 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   English Emily Chief Operations Officer   •       –      –    2025-05-12 4 OE $3.30 $24,750 D/D 7,500 55,226     -
   English Emily Chief Operations Officer   •       –      –    2025-04-15 4 OE $3.30 $24,750 D/D 7,500 47,726     -
   Springer Timothy A Director   –       •       •   2025-04-11 4 B $10.77 $391,455 I/I 36,338 656,513 2.25 0%     
   Springer Timothy A Director   –       •       •   2025-04-11 4 B $10.77 $69,074 D/D 6,412 8,643,685 3.92 0%     
   Springer Timothy A Director   –       •       •   2025-04-10 4 B $10.43 $508,751 I/I 48,595 620,175 2.25 3%     
   Springer Timothy A Director   –       •       •   2025-04-10 4 B $10.43 $89,773 D/D 8,575 8,637,273 3.92 3%     
   Springer Timothy A Director   –       •       •   2025-04-09 4 B $9.43 $393,947 I/I 41,782 571,580 2.25 -6%     
   Springer Timothy A Director   –       •       •   2025-04-09 4 B $9.43 $69,517 D/D 7,373 8,628,698 3.92 -6%     
   Springer Timothy A Director   –       •       •   2025-03-20 4 B $15.59 $855,593 D/D 54,889 8,621,325 3.92 -33%     
   Springer Timothy A Director   –       •       •   2025-03-19 4 B $14.97 $302,962 D/D 20,234 8,566,436 3.92 -31%     
   Springer Timothy A Director   –       •       •   2025-03-18 4 B $14.42 $212,599 D/D 14,740 8,546,202 3.92 -27%     
   Springer Timothy A Director   –       •       •   2025-01-14 4 B $18.00 $72,396 D/D 4,022 8,531,462 3.92 -49%     
   Springer Timothy A Director   –       •       •   2025-01-13 4 B $16.86 $293,958 D/D 16,945 8,527,440 3.92 -50%     
   Jewell Christopher M Chief Scientific Officer   •       –      –    2025-01-10 4 OE $3.23 $29,070 D/D 9,000 62,490     -
   Davis Blaine Chief Financial Officer   •       –      –    2025-01-06 4 S $16.83 $67,800 D/D (4,028) 94,811 42%     
   Miljkovic Milos Chief Medical Officer   •       –      –    2025-01-06 4 S $16.83 $15,957 D/D (948) 35,393 42%     
   English Emily Chief Operations Officer   •       –      –    2025-01-06 4 S $16.83 $15,250 D/D (906) 40,226 42%     
   Jewell Christopher M Chief Scientific Officer   •       –      –    2025-01-06 4 S $16.83 $21,646 D/D (1,286) 53,490 42%     
   Brunn Carsten President and CEO   •       •      –    2025-01-06 4 S $16.83 $146,575 D/D (8,708) 204,096 42%     
   Kurtoglu Metin Chief Technology Officer   •       –      –    2025-01-06 4 S $16.83 $41,374 D/D (2,458) 62,258 42%     
   Davis Blaine Chief Financial Officer   •       –      –    2025-01-03 4 S $16.72 $66,235 D/D (3,961) 98,839 38%     
   Miljkovic Milos Chief Medical Officer   •       –      –    2025-01-03 4 S $16.72 $15,585 D/D (932) 36,341 38%     
   English Emily Chief Operations Officer   •       –      –    2025-01-03 4 S $16.72 $14,899 D/D (891) 41,132 38%     
   Jewell Christopher M Chief Scientific Officer   •       –      –    2025-01-03 4 S $16.72 $21,136 D/D (1,264) 54,776 38%     
   Brunn Carsten President and CEO   •       •      –    2025-01-03 4 S $16.72 $143,190 D/D (8,563) 212,804 38%     
  332 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us